Cytoprotective prostaglandins for use in human intestinal diseases
US4081553A · kind A · utility
3Cited by
3References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 17, 1976 |
| Grant date | Mar 28, 1978 |
| Priority date | — |
| Expiry date | Feb 17, 1996 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/557
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for treatment of Crohn's disease, inflammatory bowel disease, infectious enteritis, sprue, and intestinal inflammatory disease secondary to radiation exposure or an intestinally-manifested allergic response to foodstuffs which comprises administrating a cytoprotective prostaglandin to a human who suffers from one of said diseases. Cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing the incidence of NOSAC-induced lesions in the intestinal wall of the rat. "NOSAC" is an abbreviation for "non-steroidal antiinflammatory compound."
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.